Article Details
Retrieved on: 2022-10-26 09:12:41
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
FDA approves the first BCMA-targeted bispecific antibody, J&J's Tecvayli, ... immunomodulatory drug, and anti-CD38 monoclonal antibody.
Article found on: pharmaphorum.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here